The biotech firm priced 3.77 million shares in a registered direct offering to fund operations and pipeline development. Alto Neuroscience priced a $100 million underwritten registered direct offering of 3.77 million common shares at $26.48 per share. All shares are being
The bank will embed Aladdin Wealth’s analytics into its myWealth Advisor platform to enhance data-driven client advice for affluent segments. Standard Chartered will integrate BlackRock’s Aladdin Wealth platform into its myWealth Advisor tool, providing relationship manage
AI Data Center Spending Is Outpacing Every Forecast on Wall Street. These 2 Stocks Are the Best Pick-and-Shovel Plays In the third quarter of 2025, Goldman Sachs analysts were trying to estimate just how much the technology hyperscalers (Alphabet, Meta, Amazon, Micr
Investors flee AI-linked equities and buy bonds as oil jumps on renewed Iran-U.S. clashes and Strait of Hormuz closure. Tech stocks led a global equity retreat and government bond yields climbed as oil prices surged on escalating Middle East tensions. MSCI’s world index sh
The miner will issue 30.1M units at C$0.045 each to fund exploration at its copper-gold-silver projects in 2026. Pacific Empire Minerals Corp (PEMC) secured C$1.355M through a non-brokered private placement of 30.1M units. Each unit, priced at C$0.045, includes one common
The B2B publisher shifts its corporate identity to reflect expansion beyond publishing into media, events, and marketing services. WTWH Media, the parent company of QSR magazine and other trade publications, has rebranded as Arrowfly. The move follows years of growth, incl
Stock market today: Dow, S&P 500, Nasdaq futures slip as US and Iran exchange fire, oil jumps Stock futures declined ahead of a busy week after the US and Iran escalated fighting in the Middle East, sending oil prices higher, and AI stocks were under pressure. Contracts on
This development, reported by Reuters, citing sources familiar with the matter, follows the approval received by Shein from the China Securities Regulatory Commission (CSRC) on 10 July 2026. According to the regulator, the retailer, which was founded in China in 2012, plan
UBS expects AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to report solid second-quarter results later this month, though it sees little room for the drugmaker to raise full-year guidance. The bank reiterated its 'buy' rating on Britain's second most valuable listed company, ahead
Quick Read - ASML's monopoly on EUV lithography and a July 15 Q2 earnings catalyst could push shares 11% higher to $2,023 from $1,831. - Unlike AMAT and LRCX, ASML sells the only EUV lithography systems on earth, where CEO Fouquet says supply cannot meet demand through 2026. - A...</stron
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.